FAKTOR-OPTIONSSCHEIN - MEDPACE HOLDINGS Share Price

Certificat

DE000MG35005

Market Closed - Bid/Ask 20:47:18 27/05/2024 BST Pre-market 07:07:27
9.85 EUR -1.30% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDPACE HOLDINGS 9.995 +1.47%
Current month-4.83%
1 month-2.18%
Date Price Change
27/05/24 9.85 -1.30%
24/05/24 9.98 -1.29%
23/05/24 10.11 0.00%
22/05/24 10.11 +3.37%
21/05/24 9.78 +1.14%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 08:47 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDPACE HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG3500
ISINDE000MG35005
Date issued 26/04/2024
Strike 585.9 $
Maturity Unlimited
Parity 17.96 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.45
Lowest since issue 9.21
Spread 0.41
Spread %4.00%

Company Profile

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Sector
-
More about the company

Ratings for Medpace Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Medpace Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
390.6 USD
Average target price
423.2 USD
Spread / Average Target
+8.35%
Consensus